UCSF and Samsung partner to accelerate validation of new digital health technologies

Published on February 24, 2014 at 1:07 AM · No Comments

Samsung Electronics Co., Ltd., and UC San Francisco (UCSF), one of the world's premier health sciences universities, today announced a partnership to accelerate validation and commercialization of promising new sensors, algorithms, and digital health technologies for preventive health solutions. The two organizations will jointly establish the UCSF-Samsung Digital Health Innovation Lab, a new space located in UCSF's Mission Bay campus in San Francisco, where some of the world's leading researchers and technologists will be able to develop and run trials to validate exciting new mobile health technologies. The joint innovation lab will be a first-of-its-kind test bed where entrepreneurs and innovators will be able to validate their technologies and accelerate the adoption of new preventive health solutions.

"Harnessing new preventative health technologies to help people live healthier lives is the next great opportunity of our generation," said Young Sohn, president and chief strategy officer of Samsung Electronics. "We invite the world's innovators and entrepreneurs to join us to validate their new sensors, analytics, and preventive health solutions in a world class setting. Samsung's global Digital Health Innovation Lab initiative is aimed at enabling great new ideas to be tested, validated, and commercialized more quickly, thereby making lives better for millions of people around the world."

The mobile health field is rapidly evolving. Advances in technologies such as wearable computing, health sensors, and cloud-based analytics promise to help people take control of their own health and to improve the quality of life for millions of people. However, without systematic, rigorous validation of these technologies, mobile health has struggled to achieve its potential and gain widespread adoption by consumers and healthcare professionals. Samsung and UCSF aim to address this challenge by leveraging UCSF's deep expertise in medicine and digital health and Samsung's leadership in electronics and mobile technologies, to rapidly develop new, effective technologies.

"There are many new sensors and devices coming onto the market for consumers, but without medical validation, most of these will have limited impacts on health. Meanwhile, many practitioners also have creative ideas for new devices, but they lack the technological knowledge to fully develop them," said Michael Blum, MD, UCSF's associate vice chancellor for Informatics. "This partnership will bring together these two very different worlds of expertise with the resources needed to accelerate new and disruptive technologies that will truly change lives."

The UCSF Mission Bay campus is an ideal location for the UCSF-Samsung Digital Health Innovation Lab and will lead to further collaborations with the broader healthcare ecosystem. The expansive new bioscience campus is a vibrant ecosystem of innovation and biotech hub, with more than 50 bioscience startups, nine established pharmaceutical and biotech companies and 10 venture capital firms.

The Digital Health Innovation Lab is part of Samsung's efforts to partner with leading global healthcare institutions to validate next-generation preventative health technologies. It also reflects a strategic goal of the UCSF Office of Innovation, Technology and Alliances to forge innovative industry partnerships that advance its work at the forefront of health and medicine. Additional information will be available at www.centerfordigitalhealthinnovation.org.

Source: UC San Francisco

Posted in: Business / Finance | Device / Technology News

Tags: , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Genomics testing in action: an interview with Kevin Haar, CEO, Appistry